OBJECTIVES: Orthotopic left lung transplantation in the mouse, as recently developed by our laboratory, represents a physiologic model for studies in transplantation biology. However, because of the limited overall respiratory contribution of the murine left lung, left lung transplant recipients remain healthy despite immune-mediated graft necrosis. We sought to develop a lung transplantation model in which animal survival depends on graft function. METHODS: Orthotopic vascularized right lung transplantations using cuff techniques were performed in syngeneic and allogeneic strain combinations. Grafts were assessed histologically or functionally by measuring arterial blood gases from 7 to 28 days after transplantation. In a parallel set of experiments, syngeneic and immunosuppressed allogeneic hosts underwent a left pneumonectomy 2 weeks after right lung transplantation, with assessment of graft function 1 week later. RESULTS: We performed 40 right lung transplantations, with a survival rate of 87.5%. Syngeneic grafts remain free of inflammation as far as 28 days after transplantation. On day 7, arterial oxygen levels in syngeneic recipients (481 +/- 90 mm Hg) are equivalent to those in naive mice (503 +/- 59 mm Hg) after left hilar occlusion. Alternatively, allogeneic grafts develop histologic evidence of acute rejection, and arterial oxygen levels are significantly decreased after left hilar clamping (53.3 +/- 10.3 mm Hg). Both syngeneic and immunosuppressed allogeneic right lung recipients tolerate a left pneumonectomy. CONCLUSIONS: Right lung transplantation followed by left pneumonectomy represents the first survival model of vascularized lung transplantation in the mouse and will therefore allow for the design of novel studies in experimental lung transplantation. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
OBJECTIVES: Orthotopic left lung transplantation in the mouse, as recently developed by our laboratory, represents a physiologic model for studies in transplantation biology. However, because of the limited overall respiratory contribution of the murine left lung, left lung transplant recipients remain healthy despite immune-mediated graft necrosis. We sought to develop a lung transplantation model in which animal survival depends on graft function. METHODS: Orthotopic vascularized right lung transplantations using cuff techniques were performed in syngeneic and allogeneic strain combinations. Grafts were assessed histologically or functionally by measuring arterial blood gases from 7 to 28 days after transplantation. In a parallel set of experiments, syngeneic and immunosuppressed allogeneic hosts underwent a left pneumonectomy 2 weeks after right lung transplantation, with assessment of graft function 1 week later. RESULTS: We performed 40 right lung transplantations, with a survival rate of 87.5%. Syngeneic grafts remain free of inflammation as far as 28 days after transplantation. On day 7, arterial oxygen levels in syngeneic recipients (481 +/- 90 mm Hg) are equivalent to those in naive mice (503 +/- 59 mm Hg) after left hilar occlusion. Alternatively, allogeneic grafts develop histologic evidence of acute rejection, and arterial oxygen levels are significantly decreased after left hilar clamping (53.3 +/- 10.3 mm Hg). Both syngeneic and immunosuppressed allogeneic right lung recipients tolerate a left pneumonectomy. CONCLUSIONS: Right lung transplantation followed by left pneumonectomy represents the first survival model of vascularized lung transplantation in the mouse and will therefore allow for the design of novel studies in experimental lung transplantation. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Authors: O A Binns; N F DeLima; S A Buchanan; M B Lopes; J T Cope; C A Marek; R C King; V E Laubach; C G Tribble; I L Kron Journal: J Thorac Cardiovasc Surg Date: 1997-08 Impact factor: 5.209
Authors: C G McGregor; J C Baldwin; S W Jamieson; M E Billingham; S A Yousem; C M Burke; P E Oyer; E B Stinson; N E Shumway Journal: J Thorac Cardiovasc Surg Date: 1985-10 Impact factor: 5.209
Authors: Dechun Li; Lucas G Fernandez; Jeffrey Dodd-o; John Langer; Danming Wang; Victor E Laubach Journal: Am J Respir Cell Mol Biol Date: 2004-12-30 Impact factor: 6.914
Authors: Andrew E Gelman; Wenjun Li; Steven B Richardson; Bernd H Zinselmeyer; Jiaming Lai; Mikio Okazaki; Christopher G Kornfeld; Friederike H Kreisel; Seiichiro Sugimoto; Jeremy R Tietjens; John Dempster; G Alexander Patterson; Alexander S Krupnick; Mark J Miller; Daniel Kreisel Journal: J Immunol Date: 2009-04-01 Impact factor: 5.422
Authors: Alexander S Krupnick; Xue Lin; Wenjun Li; Mikio Okazaki; Jiaming Lai; Seiichiro Sugimoto; Steven B Richardson; Christopher G Kornfeld; Joel R Garbow; G Alexander Patterson; Andrew E Gelman; Daniel Kreisel Journal: Nat Protoc Date: 2009 Impact factor: 13.491
Authors: M Okazaki; A S Krupnick; C G Kornfeld; J M Lai; J H Ritter; S B Richardson; H J Huang; N A Das; G A Patterson; A E Gelman; D Kreisel Journal: Am J Transplant Date: 2007-06 Impact factor: 8.086
Authors: Wenjun Li; Jason M Gauthier; Alice Y Tong; Yuriko Terada; Ryuji Higashikubo; Christian C Frye; Margaret S Harrison; Kohei Hashimoto; Amit I Bery; Jon H Ritter; Ruben G Nava; Varun Puri; Brian W Wong; Kory J Lavine; Ankit Bharat; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel Journal: J Clin Invest Date: 2020-12-01 Impact factor: 14.808
Authors: Wenjun Li; Daniel R Goldstein; Alejandro C Bribriesco; Ruben G Nava; Jessica H Spahn; Xingan Wang; Andrew E Gelman; Alexander S Krupnick; Daniel Kreisel Journal: J Thorac Dis Date: 2013-06 Impact factor: 2.895
Authors: Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel Journal: J Immunol Date: 2015-03-11 Impact factor: 5.422
Authors: Xin Jin; Janne Kaes; Jan Van Slambrouck; Ilhan Inci; Stephan Arni; Vincent Geudens; Tobias Heigl; Yanina Jansen; Marianne S Carlon; Robin Vos; Dirk Van Raemdonck; Yi Zhang; Bart M Vanaudenaerde; Laurens J Ceulemans Journal: Cells Date: 2022-01-30 Impact factor: 6.600